Bukwang Pharmaceutical Co., Ltd. Profile Avatar - Palmy Investing

Bukwang Pharmaceutical Co., Ltd.

Bukwang Pharmaceutical Co., Ltd. operates as a pharmaceutical company in South Korea and internationally. It manufactures oral solid dosage forms, injections, oral solutions, external-use solutions, and ointments. The company offers products in various t…

Drug Manufacturers - Specialty & Generic
KR, Seoul [HQ]
Financials

Analysts

Earnings
Reported
Past Estimate Consensus
Future Estimate Consensus
Bukwang Pharmaceutical Co., Ltd. can't present any analysts estimates at the moment detail analysis.
Institutional Sentiment
Morgan Stanley
1Y Ago:
n/a
Prev. Grade
n/a
Latest
n/a
JP Morgan Chase
1Y Ago:
n/a
Prev. Grade
n/a
Latest
n/a
Citigroup
1Y Ago:
n/a
Prev. Grade
n/a
Latest
n/a
Overall Consensus
Grading Consensus
Click to each, to see the grade
Bukwang Pharmaceutical Co., Ltd. can't present the grade consensus distribution right now.
Price Target Consensus
Price Then
$n/a
Price Target
$n/a
Price Now
$4595.00
End of 003000.KS's Analysis
CIK: - CUSIP: - ISIN: KR7003000007 LEI: - UEI: -
Secondary Listings
003000.KS has no secondary listings inside our databases.